Zai Lab Limited (ZLAB)
| Previous close | 32.11 |
| Open | 31.85 |
| Bid | 31.43 x 2200 |
| Ask | 31.45 x 1000 |
| Day's range | 31.00 - 32.58 |
| 52-week range | 24.50 - 181.92 |
| Volume | |
| Avg. volume | 843,985 |
| Market cap | 3.074B |
| Beta (5Y monthly) | 1.19 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -5.84 |
| Earnings date | 09 Aug 2022 - 15 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 107.94 |
- GlobeNewswire
Zai Lab Announces Upcoming Presentations at June Investor Conferences
SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that management from Zai Lab will be presenting at the following investor conferences in June: Jefferies Global Healthcare Conference 2022Presentation: Thursday, June 9, 2022, 9:00 a.m. ET Goldman Sachs 43rd Annual Global Healthcare ConferenceFireside Chat: Thursday, June 16
- GlobeNewswire
Zai Lab Announces Change to Virtual 2022 Annual General Meeting of Shareholders to be Held on June 22, 2022
SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., May 20, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that, due to the public health impact of the coronavirus (COVID-19) pandemic and the recent pandemic-related restrictions in Shanghai, the format of the 2022 Annual General Meeting of Shareholders (Annual Meeting) of Zai Lab Limited has been changed, and the Annual Meeting w
- PR Newswire
Zai Lab Announces First Quarter 2022 Financial Results and Corporate Updates
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced financial results for the first quarter of 2022, along with recent product highlights and corporate updates.
